-
A group of U.S. lawmakers have teamed up to introduce legislation to end discrimination related to HIV and AIDS. Sens. Tammy Baldwin (D-WI), Chris Coons (D-DE) and Ed Markey (D-MD) recently unveiled the “REPEAL” HIV Discrimination Act, which calls for a re-examination of laws regarding what actions can be considered criminal among people living with HIV.
-
A clinical stage biopharmaceutical company, Cellectar Biosciences Inc., recently received initial notice of an award for a Phase I-II Fast-Track Small Business Innovation Research (SBIR) grant issued for one of its cancer treatment drugs; the grant is for up to $2.3 million from the National Cancer Institute (NCI), which will be used to fund development of Cellectar's PDC platform for targeted delivery of I-125, a radiotherapeutic isotope that may be effective against micro-metastatic disease.